Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China · Delayed Price · Currency is CNY 22.88
-0.51 (-2.18%)
Oct 22, 2026, 4:00 PM EDT
SHA:688443 Market Cap
SHA:688443 has a market cap or net worth of 8.39 billion as of October 22, 2026. It is the 8,794th most valuable company in the world and the 1,804th biggest in China. Its market cap has decreased by 21.10% in one year.
Market Cap
8.39B
Enterprise Value
7.66B
Revenue
338.44M
Global Rank
Country Rank
#1,804 China
PE Ratio
n/a
ChartMarket Cap Chart
Since June 20, 2023, SHA:688443's market cap has decreased from 12.47B to 8.39B, a decrease of -32.75%. That is a compound annual growth rate of -11.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 8.39B | -16.01% |
| Dec 31, 2025 | 9.99B | 8.57% |
| Dec 31, 2024 | 9.20B | -37.20% |
| Dec 29, 2023 | 14.65B | 17.43% |
| Jun 20, 2023 | 12.47B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 9.67B |
| Chengzhi | 9.65B |
| Novoprotein Scientific | 9.28B |
| Pacific Shuanglin Bio-pharmacy | 9.04B |
| InventisBio | 8.97B |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 8.73B |
| Shanghai OPM Biosciences | 8.41B |
| Liaoning Chengda Biotechnology | 8.30B |